-
He was determined to cycle 1000km in the thirty days from July 1st but David actually did it with five days to spare. In 25 days he spent 47 hours on his cycle around the roads of Singapore to achieve … Continue reading
-
Kayleigh and co are hosting a fundraising day in aid of Secondary1st on 7th August in Totton, Hampshire. They will have food, stalls, games, raffles and good fun. They want to make a difference by increasing awareness of secondary breast … Continue reading
-
Having come back to earth after the thrill of his skydive in April Tim has been joined by Lyndell and Harry in preparation for the Brighton Marathon in September. They are training hard and have already been over the course, … Continue reading
-
To mark the halfway point in his cycle challenge to cover 1000km in thirty days David rode 50.05km on day 15 to add to his already impressive total. In the first fifteen days he has covered a total of 593.28km … Continue reading
-
David had to postpone his plan to cycle 1000km in in thirty days through Singapore because of a health problem. Now he is fully recovered and feeling fit and well he intends to start again on July 1st. He is … Continue reading
-
This week marks the fifth anniversary of the launch of Secondary1st. In all that time we have been consistently amazed by the wonderful support we have received. This has enabled us to make five significant grants to research projects investigating … Continue reading
-
Each member of the team from JH Mechanical Services has been challenged to walk or run 500 miles in the seven months between the beginning of April and the end of October to raise money for Secondary1st. Heather completed her … Continue reading
-
He planned to cycle 1000km in thirty days in the heat and humidity of Singapore to raise money for Secondary1st. In the first two days he covered more than 80 km so he was well on track to complete his … Continue reading
-
A drug trial for Olaparib, also known as Lynparza, has shown good results for women with breast cancer who have faulty variants in BRCA1 or BRCA2 genes. In the trial 85.9% of women given Olaparib for one year after the … Continue reading
-
In 2017 David cycled all the way from London to Amsterdam to raise money for Secondary1st. He had recently lost his wife Joanne to secondary breast cancer and Secondary1st was a charity which had been very close to her heart. … Continue reading